R. Leikin

Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy.

W. Catalona, T. Kuzel, I. Helenowski, 2020, Urologic oncology.

The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy.

W. Catalona, T. Kuzel, I. Helenowski, 2021, Urologic oncology.

A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA.

D. Weiner, S. Rosen, S. Pillay, 1992, Blood.